<article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         dtd-version="1.0"
         article-type="research-article">
   <front>
      <journal-meta>
         <journal-id journal-id-type="jstor">intejhealcarefin</journal-id>
         <journal-id journal-id-type="jstor">j100925</journal-id>
         <journal-title-group>
            <journal-title>International Journal of Health Care Finance and Economics</journal-title>
         </journal-title-group>
         <publisher>
            <publisher-name>Springer Science+Business Media</publisher-name>
         </publisher>
         <issn pub-type="ppub">13896563</issn>
         <issn pub-type="epub">15736962</issn>
         <custom-meta-group/>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="jstor">40270629</article-id>
         <article-id pub-id-type="pub-doi">10.1007/s10754-008-9049-8</article-id>
         <title-group>
            <article-title>The Potential Premium Range of Risk-Rating in Competitive Markets for Supplementary Health Insurance</article-title>
         </title-group>
         <contrib-group>
            <contrib>
               <string-name>
                  <given-names>Francesco</given-names>
                  <surname>Paolucci</surname>
               </string-name>
            </contrib>
            <contrib>
               <string-name>
                  <given-names>Femmeke</given-names>
                  <surname>Prinsze</surname>
               </string-name>
            </contrib>
            <contrib>
               <string-name>
                  <given-names>Pieter J. A.</given-names>
                  <surname>Stam</surname>
               </string-name>
            </contrib>
            <contrib>
               <string-name>
                  <given-names>Wynand P. M. M.</given-names>
                  <surname>van de Yen</surname>
               </string-name>
            </contrib>
         </contrib-group>
         <pub-date>
            <day>1</day>
            <month>9</month>
            <year>2009</year>
         </pub-date>
         <volume xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">9</volume>
         <issue xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">3</issue>
         <issue-id>i40010624</issue-id>
         <fpage>243</fpage>
         <lpage>258</lpage>
         <permissions>
            <copyright-statement/>
         </permissions>
         <self-uri xlink:href="https://www.jstor.org/stable/40270629"/>
         <abstract>
            <p>In this paper, we simulate several scenarios of the potential premium range for voluntary (supplementary) health insurance, covering benefits which might be excluded from mandatory health insurance (MI). Our findings show that, by adding risk- factors, the minimum premium decreases and the maximum increases. The magnitude of the premium range is especially substantial for benefits such as medical devices and drugs. When removing benefits from MI policymakers should be aware of the implications for the potential reduction of affordability of voluntary health insurance coverage in a competitive market.</p>
         </abstract>
         <kwd-group>
            <kwd>Risk-rating</kwd>
            <kwd>Supplementary health insurance</kwd>
            <kwd>Competition</kwd>
            <kwd>Affordability</kwd>
            <kwd>I10</kwd>
            <kwd>I11</kwd>
            <kwd>I18</kwd>
            <kwd>I19</kwd>
         </kwd-group>
         <custom-meta-group>
            <custom-meta>
               <meta-name>lang</meta-name>
               <meta-value>eng</meta-value>
            </custom-meta>
         </custom-meta-group>
      </article-meta>
   </front>
   <back>
      <fn-group>
         <title>[Footnotes]</title>
         <fn id="d26e182a1310">
            <label>1</label>
            <p>
               <mixed-citation id="d26e189" publication-type="other">
(Colombo and Tapay 2004).</mixed-citation>
            </p>
            <p>
               <mixed-citation id="d26e195" publication-type="other">
(Van de Ven et al. 2003, 2004, 2007).</mixed-citation>
            </p>
         </fn>
         <fn id="d26e202a1310">
            <label>3</label>
            <p>
               <mixed-citation id="d26e209" publication-type="other">
Council Directive 2004/113/EC of December 2004,</mixed-citation>
            </p>
            <p>
               <mixed-citation id="d26e215" publication-type="other">
EC Treaty 1997</mixed-citation>
            </p>
            <p>
               <mixed-citation id="d26e221" publication-type="other">
(Art. 5(2), Direc-
tive 2004/113/EC).</mixed-citation>
            </p>
            <p>
               <mixed-citation id="d26e231" publication-type="other">
(Armstrong et al. 2004).</mixed-citation>
            </p>
         </fn>
         <fn id="d26e238a1310">
            <label>4</label>
            <p>
               <mixed-citation id="d26e245" publication-type="other">
Paolucci et al. (2007),</mixed-citation>
            </p>
         </fn>
         <fn id="d26e252a1310">
            <label>5</label>
            <p>
               <mixed-citation id="d26e259" publication-type="other">
(Paolucci et al. 2007).</mixed-citation>
            </p>
         </fn>
         <fn id="d26e267a1310">
            <label>10</label>
            <p>
               <mixed-citation id="d26e274" publication-type="other">
(Van Kolfschooten 2003).</mixed-citation>
            </p>
         </fn>
      </fn-group>
      <ref-list>
         <title>References</title>
         <ref id="d26e290a1310">
            <mixed-citation id="d26e294" publication-type="other">
Armstrong, J., et al. (2004). Report to the South African Risk Equalization Fund Task Group. The International
Review Panel, pp. 19-25.</mixed-citation>
         </ref>
         <ref id="d26e304a1310">
            <mixed-citation id="d26e308" publication-type="other">
Article 5(2) of the Council Directive 2004/113/EC of December 2004. Implementing the principle of equal
treatment between men and women in the access to and supply of goods and services. http://eur-lex.europa.
eu/LexUriServ/site/en/oj/2004/l_373/l_37320041221en00370043.pdf. Accessed 6 June 2006.</mixed-citation>
         </ref>
         <ref id="d26e321a1310">
            <mixed-citation id="d26e325" publication-type="other">
Article 13 of the EC Treaty, signed in Amsterdam in October 1997.</mixed-citation>
         </ref>
         <ref id="d26e332a1310">
            <mixed-citation id="d26e336" publication-type="other">
Buchmueller, T. C., &amp; Feldstein, P. J. (1997). The effect of price on switching among health plans. Journal of
Health Economics, 16, 231-247. doi:10.10167S0167-6296(96)00531-0.</mixed-citation>
         </ref>
         <ref id="d26e347a1310">
            <mixed-citation id="d26e351" publication-type="other">
Colombo, F., &amp; Tapay, N. (2004). Private health insurance in Ireland: A case study. OECD Health Working
Paper, NO. 10, DELSA/ELSA/WD/HEA.</mixed-citation>
         </ref>
         <ref id="d26e361a1310">
            <mixed-citation id="d26e365" publication-type="other">
Desmond, K. A., Rice, T., &amp; Fox, P.D.(2006). Does grater Medicare HMO enrolment cause adverse selection
into Medigap? Health Economics, Policy and Law, 1, 3-21. doi: 10.1017/S1744133105001039.</mixed-citation>
         </ref>
         <ref id="d26e375a1310">
            <mixed-citation id="d26e379" publication-type="other">
Herring, B., &amp; Pauly, M. V. (2001). Premium variation in the individual health insurance market. International
Journal of Health Care Finance and Economics, 1,43-58. doi: 10.1023/A: 1011599905462.</mixed-citation>
         </ref>
         <ref id="d26e389a1310">
            <mixed-citation id="d26e393" publication-type="other">
Lamers, L. M., &amp; van Vliet, R. C. J. A. (1996). Multiyear diagnostic information from prior hospital-
izations as a risk-adjuster for capitation payments. Medical Care, 34(6), 549-561.doi:10.1097/00005650-
199606000-00005.</mixed-citation>
         </ref>
         <ref id="d26e406a1310">
            <mixed-citation id="d26e410" publication-type="other">
Newhouse, J. P. (1996). Reimbursing health plans and health providers: Efficiency in production versus selec-
tion. Journal of Economic Literature, 34(3), 1236-1263.</mixed-citation>
         </ref>
         <ref id="d26e420a1310">
            <mixed-citation id="d26e424" publication-type="other">
Organisation for Economic Co-operation and Development. (2004). Private health insurance in OECD coun-
tries. The OECD Health Project. OECD, 2004.</mixed-citation>
         </ref>
         <ref id="d26e435a1310">
            <mixed-citation id="d26e439" publication-type="other">
Paolucci, F. (2007). The design of basic and supplementary health care financing schemes: Implications for
efficiency and affordability. Dissertation, Erasmus University Rotterdam.</mixed-citation>
         </ref>
         <ref id="d26e449a1310">
            <mixed-citation id="d26e453" publication-type="other">
Paolucci, F., Schut, E., Beck, K., van de Voorde, C., GreB, S., &amp; Zmora, I. (2007). Supplementary health insur-
ance as a tool for risk-selection in mandatory basic health insurance markets: A five-country comparison.
Health Economics, Policy and Law, 2, 173-192. doi:10.1017/S1744133107004124.</mixed-citation>
         </ref>
         <ref id="d26e466a1310">
            <mixed-citation id="d26e470" publication-type="other">
Paolucci, F., van de Ven, W. P. M. M, &amp; den Exter, A. (2006). Solidarity in competitive health insurance
markets: Analysing the relevant EC legal framework. Health Economics, Policy and Law, 1(2),107-126.
doi:10.l017/S1744133105000137.</mixed-citation>
         </ref>
         <ref id="d26e483a1310">
            <mixed-citation id="d26e487" publication-type="other">
Pauly, M. V., &amp; Herring, B. (2007). Risk pooling and regulation: Policy and reality in today's individual health
insurance market. Health Affairs, 26(3), 770-779. doi:10.1377/hlthaff.26.3.770.</mixed-citation>
         </ref>
         <ref id="d26e497a1310">
            <mixed-citation id="d26e501" publication-type="other">
Pope, G. C., etal. (1999). Principal inpatient diagnostic cost group models for Medicare risk adjustment. Final
Report to the Health Care Financing Administration. Waltham, MA: Health Economics Research, Inc.</mixed-citation>
         </ref>
         <ref id="d26e511a1310">
            <mixed-citation id="d26e515" publication-type="other">
Pope, G. C., etal. (2000). The principal inpatient diagnostic cost group model for Medicare risk adjustment.
Health Care Financing Review, 21(3), 93-118.</mixed-citation>
         </ref>
         <ref id="d26e526a1310">
            <mixed-citation id="d26e530" publication-type="other">
Prinsze, F.J., &amp; van Vliet, R. C. J. A. (2007). Health-based risk adjustment: Improving the pharmacy-based
cost group model by adding diagnostic cost groups. Inquiry, 44, 469-480.</mixed-citation>
         </ref>
         <ref id="d26e540a1310">
            <mixed-citation id="d26e544" publication-type="other">
Schut, E., Laske-Aldershof, T., &amp; de Bruijn, D. (2004). Effecten van de aanvullende ziekenfondsverzekering
op de hoofdverzekering: een theoretische en empirische analyse (Effects of supplementary sickness fund
insurance on basic insurance: A theoretical and empirical analysis). Research memorandum for the Dutch
Ministry of Health (VWS), Erasmus University Rotterdam.</mixed-citation>
         </ref>
         <ref id="d26e560a1310">
            <mixed-citation id="d26e564" publication-type="other">
Strombom, B. A., Buchmueller, T. C, &amp; Feldstein, P. J. (2002). Switching costs, price sensitivity and health
plan choice. Journal of Health Economics, 21, 89-116.doi:10.1016/S0167-6296(01)00124-2.</mixed-citation>
         </ref>
         <ref id="d26e574a1310">
            <mixed-citation id="d26e578" publication-type="other">
Uccello, C. E., &amp; Bertko, J. M. (2003). Medicare prescription drugs plans: the devil is in the details, http://
www.actuary.org/pdf/medicare/drugbenefit_sept02.pdf . American Academy of Actuaries. Accessed 6 June
2006.</mixed-citation>
         </ref>
         <ref id="d26e591a1310">
            <mixed-citation id="d26e595" publication-type="other">
Van de Ven, W. P. M. M., &amp; Ellis, R. P. (2000). Risk adjustment in competitive health plan markets. In A. J.
Culyer &amp; J. P. Newhouse (Eds.), Handbook of health economics (pp. 754-837). Amsterdam: Elsevier.</mixed-citation>
         </ref>
         <ref id="d26e605a1310">
            <mixed-citation id="d26e609" publication-type="other">
Van de Ven, W. P. M. M., &amp; Schut, F. T. (2007). Risk equalization in an individual health insurance mar-
ket: The only escape from the tradeoff between affordability, efficiency and selection: The Netherlands as
a Case Study. http://www.fresh-thinking.org/docs/workshop_070503/PaperVande VenSchutO2aprO7.pdf.
Accessed 20 May 2007.</mixed-citation>
         </ref>
         <ref id="d26e626a1310">
            <mixed-citation id="d26e630" publication-type="other">
Van de Ven, W. P. M. M., et al. (2003). Risk adjustment and risk selection on the sickness fund insurance
market in five European countries. Health Policy (Amsterdam), 65(1), 75-98. doi:10.1016/S0168-
8510(02)00118-5.</mixed-citation>
         </ref>
         <ref id="d26e643a1310">
            <mixed-citation id="d26e647" publication-type="other">
Van de Ven, W. P. M. M., et al. (2007). Risk adjustment and risk selection in Europe: 6years later. Health
Policy (Amsterdam), 83(2-3), 162-179. doi:10.1016/j.healthpol.2006.12.004.</mixed-citation>
         </ref>
         <ref id="d26e657a1310">
            <mixed-citation id="d26e661" publication-type="other">
Van de Ven, W. P. M. M., van Vliet, R. C. J. A., &amp; Lamers, L. M. (2004). Health-adjusted premium subsidies
in the Netherlands. Health Affairs, 23(6), 45-55. doi: 10.1377/hlthafT.23.3.45.</mixed-citation>
         </ref>
         <ref id="d26e671a1310">
            <mixed-citation id="d26e675" publication-type="other">
Van de Ven, W. P. M. M., et al. (2000). Access to coverage for high-risks in a competitive individual health
insurance market: Via premium rate restrictions or risk-adjusted premium subsidies? Journal of Health
Economics, 19(3), 311-339. doi:10.1016/S0167-6296(99)00028-4.</mixed-citation>
         </ref>
         <ref id="d26e688a1310">
            <mixed-citation id="d26e692" publication-type="other">
Van Kolfschooten, F. (2003). Dutch Government announces large cuts in health spending. Lancet, 362, 1048.
doi:10.1016/S0140-6736(03)14453-4.</mixed-citation>
         </ref>
      </ref-list>
   </back>
</article>
